Literature DB >> 12603774

Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.

H Vanden Bossche1, M Engelen, F Rochette.   

Abstract

A limited number of antifungal agents is licensed for use in animals, however, many of those available for the treatment of mycoses in humans are used by veterinary practitioners. This review includes chemical aspects, spectra of activity, mechanisms of action and resistance, adverse reactions and drug interactions of the antifungals in current use.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12603774     DOI： 10.1046/j.1365-2885.2003.00456.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN： 0140-7783            Impact factor:   1.786


  16 in total

Review 1.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

2.  In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Authors:  Juliana S Argenta; Janio M Santurio; Sydney H Alves; Daniela I B Pereira; Ayrton S Cavalheiro; Andréia Spanamberg; Laerte Ferreiro
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

3.  Anti-Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole.

Authors:  Ce Shi; Chunli Liu; Jinyan Liu; Ying Wang; Jian Li; Mingjie Xiang
Journal:  Mycopathologia       Date:  2015-05-15       Impact factor: 2.574

4.  The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.

Authors:  Ann R Holmes; Mikhail V Keniya; Irena Ivnitski-Steele; Brian C Monk; Erwin Lamping; Larry A Sklar; Richard D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

Review 5.  Sterol metabolism in the opportunistic pathogen Pneumocystis: advances and new insights.

Authors:  Edna S Kaneshiro
Journal:  Lipids       Date:  2004-08       Impact factor: 1.880

6.  Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin.

Authors:  Ryan A Helmick; Arin E Fletcher; Anne M Gardner; Christopher R Gessner; Angela N Hvitved; Michael C Gustin; Paul R Gardner
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 7.  Clinically relevant drug-drug interactions between antiretrovirals and antifungals.

Authors:  Ramya Krishna Vadlapatla; Mitesh Patel; Durga K Paturi; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-02-12       Impact factor: 4.481

8.  The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.

Authors:  Hugo Vanden Bossche; Jannie Ausma; Hilde Bohets; Karen Vermuyten; Gustaaf Willemsens; Patrick Marichal; Lieven Meerpoel; Frank Odds; Marcel Borgers
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Polyhexamethyl biguanide can eliminate contaminant yeasts from fuel-ethanol fermentation process.

Authors:  Carolina Elsztein; João Assis Scavuzzi de Menezes; Marcos Antonio de Morais
Journal:  J Ind Microbiol Biotechnol       Date:  2008-05-28       Impact factor: 3.346

10.  CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole.

Authors:  Patrícia da Silva Nascente; Ana Raquel Mano Meinerz; Renata Osório de Faria; Luiz Filipe Damé Schuch; Mário Carlos Araújo Meireles; João Roberto Braga de Mello
Journal:  Braz J Microbiol       Date:  2009-06-01       Impact factor: 2.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.